SFRP1 and systemic sclerosis: Transcriptional silencing of Sfrp1 was previously reported in non-small cell lung cancer42 and in fibroblasts derived from keloid lesions43, Systemic Sclerosis (SSc)44, and IPF fibrotic lungs45.